Year-over-year, this metric declined by 4.2%, from $1.08M to $1.04M. Over 3 years (FY 2022 to FY 2025), Other Non-Current Liabilities shows a downward trend with a -100.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $898.00K | $1.02M | $584.00K | $541.00K | $540.00K | $540.00K | $540.00K | $1.08M | $531.00K | $525.00K | $0.00 | $1.04M |
| QoQ Change | — | +13.8% | -42.9% | -7.4% | -0.2% | +0.0% | +0.0% | +100.4% | -50.9% | -1.1% | -100.0% | — |
| YoY Change | — | — | -35.0% | — | — | -47.2% | -7.5% | +100.0% | -1.7% | -2.8% | -100.0% | -4.2% |